124 related articles for article (PubMed ID: 20652801)
1. Soluble epithin/PRSS14 secreted from cancer cells contains active angiogenic potential.
Kim SB; Lee D; Jeong JW; Kim C; Park D; Kim MG
Mol Cells; 2010 Jun; 29(6):617-23. PubMed ID: 20652801
[TBL] [Abstract][Full Text] [Related]
2. PRSS14/Epithin is induced in macrophages by the IFN-γ/JAK/STAT pathway and mediates transendothelial migration.
Lee D; Lee HS; Yang SJ; Jeong H; Kim DY; Lee SD; Oh JW; Park D; Kim MG
Biochem Biophys Res Commun; 2011 Feb; 405(4):644-50. PubMed ID: 21295011
[TBL] [Abstract][Full Text] [Related]
3. A JUN N-terminal kinase inhibitor induces ectodomain shedding of the cancer-associated membrane protease Prss14/epithin via protein kinase CβII.
Yoon J; Cho Y; Kim KY; Yoon MJ; Lee HS; Jeon SD; Cho Y; Kim C; Kim MG
J Biol Chem; 2020 May; 295(20):7168-7177. PubMed ID: 32241917
[TBL] [Abstract][Full Text] [Related]
4. Intramembrane proteolysis of an extracellular serine protease, epithin/PRSS14, enables its intracellular nuclear function.
Cho Y; Kim SB; Kim J; Pham AVQ; Yoon MJ; Park JH; Hwang KT; Park D; Cho Y; Kim MG; Kim C
BMC Biol; 2020 Jun; 18(1):60. PubMed ID: 32493324
[TBL] [Abstract][Full Text] [Related]
5. Environment-Sensitive Ectodomain Shedding of Epithin/PRSS14 Increases Metastatic Potential of Breast Cancer Cells by Producing CCL2.
Jang J; Cho EH; Cho Y; Ganzorig B; Kim KY; Kim MG; Kim C
Mol Cells; 2022 Aug; 45(8):564-574. PubMed ID: 35950457
[TBL] [Abstract][Full Text] [Related]
6. Epithin/PRSS14 proteolytically regulates angiopoietin receptor Tie2 during transendothelial migration.
Kim C; Lee HS; Lee D; Lee SD; Cho EG; Yang SJ; Kim SB; Park D; Kim MG
Blood; 2011 Jan; 117(4):1415-24. PubMed ID: 21097670
[TBL] [Abstract][Full Text] [Related]
7. Shedding of epithin/PRSS14 is induced by TGF-β and mediated by tumor necrosis factor-α converting enzyme.
Lee HS; Park BM; Cho Y; Kim S; Kim C; Kim MG; Park D
Biochem Biophys Res Commun; 2014 Oct; 452(4):1084-90. PubMed ID: 25245289
[TBL] [Abstract][Full Text] [Related]
8. Targeting metastatic breast cancer with peptide epitopes derived from autocatalytic loop of Prss14/ST14 membrane serine protease and with monoclonal antibodies.
Kim KY; Yoon M; Cho Y; Lee KH; Park S; Lee SR; Choi SY; Lee D; Yang C; Cho EH; Jeon SD; Kim SH; Kim C; Kim MG
J Exp Clin Cancer Res; 2019 Aug; 38(1):363. PubMed ID: 31426843
[TBL] [Abstract][Full Text] [Related]
9. The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.
Friedli A; Fischer E; Novak-Hofer I; Cohrs S; Ballmer-Hofer K; Schubiger PA; Schibli R; Grünberg J
Int J Biochem Cell Biol; 2009 Jul; 41(7):1572-80. PubMed ID: 19401151
[TBL] [Abstract][Full Text] [Related]
10. Epithin, a target of transforming growth factor-beta signaling, mediates epithelial-mesenchymal transition.
Lee HS; Kim C; Kim SB; Kim MG; Park D
Biochem Biophys Res Commun; 2010 May; 395(4):553-9. PubMed ID: 20398629
[TBL] [Abstract][Full Text] [Related]
11. N-terminal processing is essential for release of epithin, a mouse type II membrane serine protease.
Cho EG; Kim MG; Kim C; Kim SR; Seong IS; Chung C; Schwartz RH; Park D
J Biol Chem; 2001 Nov; 276(48):44581-9. PubMed ID: 11567025
[TBL] [Abstract][Full Text] [Related]
12. Endothelial CD146 is required for in vitro tumor-induced angiogenesis: the role of a disulfide bond in signaling and dimerization.
Zheng C; Qiu Y; Zeng Q; Zhang Y; Lu D; Yang D; Feng J; Yan X
Int J Biochem Cell Biol; 2009 Nov; 41(11):2163-72. PubMed ID: 19782948
[TBL] [Abstract][Full Text] [Related]
13. Impact of suppression of tumorigenicity 14 (ST14)/serine protease 14 (Prss14) expression analysis on the prognosis and management of estrogen receptor negative breast cancer.
Kim S; Yang JW; Kim C; Kim MG
Oncotarget; 2016 Jun; 7(23):34643-63. PubMed ID: 27167193
[TBL] [Abstract][Full Text] [Related]
14. Autocrine human growth hormone promotes tumor angiogenesis in mammary carcinoma.
Brunet-Dunand SE; Vouyovitch C; Araneda S; Pandey V; Vidal LJ; Print C; Mertani HC; Lobie PE; Perry JK
Endocrinology; 2009 Mar; 150(3):1341-52. PubMed ID: 18974274
[TBL] [Abstract][Full Text] [Related]
15. Matriptase/epithin participates in mammary epithelial cell growth and morphogenesis through HGF activation.
Lee SL; Huang PY; Roller P; Cho EG; Park D; Dickson RB
Mech Dev; 2010; 127(1-2):82-95. PubMed ID: 19853659
[TBL] [Abstract][Full Text] [Related]
16. Targeting oncogenic serine/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia.
Bottos A; Martini M; Di Nicolantonio F; Comunanza V; Maione F; Minassi A; Appendino G; Bussolino F; Bardelli A
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):E353-9. PubMed ID: 22203991
[TBL] [Abstract][Full Text] [Related]
17. Danshensu has anti-tumor activity in B16F10 melanoma by inhibiting angiogenesis and tumor cell invasion.
Zhang LJ; Chen L; Lu Y; Wu JM; Xu B; Sun ZG; Zheng SZ; Wang AY
Eur J Pharmacol; 2010 Sep; 643(2-3):195-201. PubMed ID: 20621088
[TBL] [Abstract][Full Text] [Related]
18. Matriptase-2 inhibits HECV motility and tubule formation in vitro and tumour angiogenesis in vivo.
Webb SL; Sanders AJ; Mason MD; Jiang WG
Mol Cell Biochem; 2013 Mar; 375(1-2):207-17. PubMed ID: 23238872
[TBL] [Abstract][Full Text] [Related]
19. Shedding of membrane epithin is blocked without LDLRA4 and its protease activation site.
Cho EG; Schwartz RH; Kim MG
Biochem Biophys Res Commun; 2005 Feb; 327(1):328-34. PubMed ID: 15629466
[TBL] [Abstract][Full Text] [Related]
20. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling.
Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE
PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
